| Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes NE Stevens, MJ Chapman, CK Fraser, TR Kuchel, JD Hayball, KR Diener Scientific reports 7 (1), 5850, 2017 | 116 | 2017 |
| Antimicrobial polymethacrylates synthesized as mimics of tryptophan-rich cationic peptides KES Locock, TD Michl, N Stevens, JD Hayball, K Vasilev, A Postma, ... ACS Macro Letters 3 (4), 319-323, 2014 | 112 | 2014 |
| Randomized trial of BCG vaccine to protect against Covid-19 in health care workers LF Pittet, NL Messina, F Orsini, CL Moore, V Abruzzo, S Barry, R Bonnici, ... New England Journal of Medicine 388 (17), 1582-1596, 2023 | 90 | 2023 |
| RAFT-derived antimicrobial polymethacrylates: elucidating the impact of end-groups on activity and cytotoxicity TD Michl, KES Locock, NE Stevens, JD Hayball, K Vasilev, A Postma, ... Polymer Chemistry 5 (19), 5813-5822, 2014 | 87 | 2014 |
| Depletion of high‐affinity corticosteroid‐binding globulin corresponds to illness severity in sepsis and septic shock; clinical implications MA Nenke, W Rankin, MJ Chapman, NE Stevens, KR Diener, JD Hayball, ... Clinical endocrinology 82 (6), 801-807, 2015 | 54 | 2015 |
| BCG vaccination to reduce the impact of COVID-19 in healthcare workers: protocol for a randomised controlled trial (BRACE trial) LF Pittet, NL Messina, K Gardiner, F Orsini, V Abruzzo, S Bannister, ... BMJ open 11 (10), e052101, 2021 | 36 | 2021 |
| Skin barrier and autoimmunity—mechanisms and novel therapeutic approaches for autoimmune blistering diseases of the skin NE Stevens, AJ Cowin, Z Kopecki Frontiers in Immunology 10, 1089, 2019 | 30 | 2019 |
| A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines FJ Ryan, TS Norton, C McCafferty, SJ Blake, NE Stevens, J James, ... Cell Reports Medicine 4 (3), 2023 | 29 | 2023 |
| Off‐target effects of bacillus Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2: implications for protection against severe COVID‐19 NL Messina, S Germano, R McElroy, R Rudraraju, R Bonnici, LF Pittet, ... Clinical & translational immunology 11 (4), e1387, 2022 | 28 | 2022 |
| The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiota SJ Blake, J James, FJ Ryan, J Caparros-Martin, GL Eden, YC Tee, ... Cell Reports Medicine 2 (12), 2021 | 23 | 2021 |
| CoVaccine HT™ adjuvant is superior to Freund's adjuvants in eliciting antibodies against the endogenous alarmin HMGB1 N Lakhan, NE Stevens, KR Diener, JD Hayball Journal of immunological methods 439, 37-43, 2016 | 18 | 2016 |
| Flightless I alters the inflammatory response and autoantibody profile in an OVA-induced atopic dermatitis skin-like disease Z Kopecki, NE Stevens, HT Chong, GN Yang, AJ Cowin Frontiers in Immunology 9, 1833, 2018 | 15 | 2018 |
| Recombinant leucine-rich repeat flightless-interacting protein-1 improves healing of acute wounds through its effects on proliferation inflammation and collagen deposition Z Kopecki, NE Stevens, GN Yang, E Melville, AJ Cowin International Journal of Molecular Sciences 19 (7), 2014, 2018 | 12 | 2018 |
| An empirical approach towards the efficient and optimal production of influenza-neutralizing ovine polyclonal antibodies demonstrates that the novel adjuvant CoVaccine HT™ is … NE Stevens, CK Fraser, M Alsharifi, MP Brown, KR Diener, JD Hayball PLoS One 8 (7), e68895, 2013 | 12 | 2013 |
| Preserved antiviral adaptive immunity following polyclonal antibody immunotherapy for severe murine influenza infection NE Stevens, A Hatjopolous, CK Fraser, M Alsharifi, KR Diener, JD Hayball Scientific reports 6 (1), 29154, 2016 | 11 | 2016 |
| Overcoming the challenges of topical antibody administration for improving healing outcomes: A review of recent laboratory and clinical approaches NE Stevens, AJ Cowin Wound Practice & Research: Journal of the Australian Wound Management …, 2017 | 9 | 2017 |
| Immunisation with the BCG and DTPw vaccines induces different programs of trained immunity in mice NE Stevens, M van Wolfswinkel, W Bao, FJ Ryan, B Brook, N Amenyogbe, ... Vaccine 40 (11), 1594-1605, 2022 | 8 | 2022 |
| No evidence of durable trained immunity after two doses of adenovirus-vectored or mRNA COVID-19 vaccines NE Stevens, FJ Ryan, NL Messina, SJ Blake, TS Norton, S Germano, ... The Journal of clinical investigation 133 (17), 2023 | 6 | 2023 |
| Colostrum is required for the postnatal ontogeny of small intestine innate lymphoid type 2 cells and successful anti‐helminth defences A Rekima, L van den Elsen, C Isnard, DJ Smyth, MA Lynn, T Yee, ... Allergy, 2024 | 4 | 2024 |
| Bacille Calmette-Guérin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trial LF Pittet, NL Messina, E McDonald, F Orsini, S Barry, M Bonten, ... EClinicalMedicine 72, 2024 | 3 | 2024 |
John HayballProfessor, University of South AustraliaEmail verificata su unisa.edu.au